about
Epimutational profile of hematologic malignancies as attractive target for new epigenetic therapiesMammalian SWI/SNF chromatin remodeling complexes and cancer: Mechanistic insights gained from human genomicsUndercover: gene control by metabolites and metabolic enzymesAging-Induced Stem Cell Mutations as Drivers for Disease and CancerGenome-wide mapping of histone H3K9me2 in acute myeloid leukemia reveals large chromosomal domains associated with massive gene silencing and sites of genome instability.Combattre les maladies négligées en ciblant sélectivement leurs enzymes épigénétiques : le cas de la désacétylase 8 (HDAC8) de Schistosoma mansoni.Depletion of Histone Demethylase Jarid1A Resulting in Histone Hyperacetylation and Radiation Sensitivity Does Not Affect DNA Double-Strand Break Repair.Reading between the Lines: "ADD"-ing Histone and DNA Methylation Marks toward a New Epigenetic "Sum".Human papillomaviruses: research priorities for the next decade.Epigenetics of hematopoiesis and hematological malignancies.Regulation of Replication Fork Advance and Stability by Nucleosome Assembly.Diverse interventions that extend mouse lifespan suppress shared age-associated epigenetic changes at critical gene regulatory regionsPSIP1/p75 promotes tumorigenicity in breast cancer cells by promoting the transcription of cell cycle genes.MLL3/MLL4/COMPASS Family on Epigenetic Regulation of Enhancer Function and Cancer.Genome maintenance in the context of 4D chromatin condensation.Epigenetic balance of gene expression by Polycomb and COMPASS families.Greater Than the Sum of Parts: Complexity of the Dynamic Epigenome.Extremely low-frequency magnetic fields and risk of childhood leukemia: A risk assessment by the ARIMMORA consortium.Centromere Stability: The Replication Connection.Super-Enhancer-Driven Transcriptional Dependencies in Cancer.Xist RNA repeat E is essential for ASH2L recruitment to the inactive X and regulates histone modifications and escape gene expression.A systems medicine approach for finding target proteins affecting treatment outcomes in patients with non-Hodgkin lymphoma.The Greater Genomic Landscape: The Heterogeneous Evolution of Cancer.Heterochromatin Reduction Correlates with the Increase of the KDM4B and KDM6A Demethylases and the Expression of Pericentromeric DNA during the Acquisition of a Transformed Phenotype.Dynamics of BAF-Polycomb complex opposition on heterochromatin in normal and oncogenic statesSuv39h1 links the SUMO pathway to constitutive heterochromatin.The histone variant H3.3 G34W substitution in giant cell tumor of the bone link chromatin and RNA processing.Identification of DNA Methylation-Independent Epigenetic Events Underlying Clear Cell Renal Cell Carcinoma.Identifying new targets for cancer drug 5'-fluorouracil.Machine Learning for Nuclear Mechano-Morphometric Biomarkers in Cancer Diagnosis.Modulation of DNA methylation by human papillomavirus E6 and E7 oncoproteins in cervical cancer.Neuron-specific alternative splicing of transcriptional machineries: Implications for neurodevelopmental disorders.A cryptic Tudor domain links BRWD2/PHIP to COMPASS-mediated histone H3K4 methylation.Aneuploidy as a cause of impaired chromatin silencing and mating-type specification in budding yeast.H3.1 K36M mutation in a congenital-onset soft tissue neoplasm.A systematic assessment of chemical, genetic, and epigenetic factors influencing the activity of anticancer drug KP1019 (FFC14A).Not All H3K4 Methylations Are Created Equal: Mll2/COMPASS Dependency in Primordial Germ Cell Specification.Composition and Function of Mutant Swi/Snf Complexes.The CREBBP Acetyltransferase Is a Haploinsufficient Tumor Suppressor in B-cell Lymphoma.Resetting the epigenetic balance of Polycomb and COMPASS function at enhancers for cancer therapy
P2860
Q26744080-647FDFCF-6E3F-4844-A7EB-33778053AA9DQ26776098-85183D03-CBD0-40D4-AE56-0797F2C07FAFQ28072281-4F3DADA4-4772-499B-811B-18F272AE74EDQ28384025-45AAEB5E-39C0-452A-994F-D5B8B96F6453Q30252934-60AB1F7F-463A-4733-9750-58F29FC19208Q30315847-FEA360E4-1BBF-4C33-846B-772402209115Q36038071-DF26703B-03FA-44A0-B38D-78CB2D3479F9Q36703430-C62F1CCD-028B-44F1-9B10-1F328F252A22Q37241711-60A0A256-13D2-43B7-87AD-EECF41E6ACDDQ37343797-115AC7B1-6EAC-49B3-82B2-89DE81D48F63Q37676224-9FCF45CE-54A7-411B-8816-95331D4D794EQ37726297-F2CB9736-23F8-4690-BF65-6250A8FF149EQ38716883-5409BC68-F1DB-4A7B-9CD8-9D2AC3CF822CQ38800948-B6D3F25E-DD6B-4391-A559-EB1714C4FB54Q38813244-17DE4B42-0D36-4A08-AB36-6773F2C7A692Q38852455-144F11FD-79B8-4AC3-A42A-1B147E427DD5Q38853113-11DB703B-7A11-4F29-AB65-AF3AAC04E201Q38893180-E94C3742-EF5A-464F-BDA6-0B37E9FDCECAQ39010240-BF50F767-2326-437F-AE02-0157C68E47CCQ39441366-2CFF4195-F782-4F4F-8346-093B306A12C1Q41090643-FE326F1C-E055-43B8-BDF4-5D5FEC1DC579Q41367937-23EDE803-250B-4767-AFB9-D9F191B36E0EQ41608657-667C64A9-F55D-4E7A-B632-CA5CE7E71FDBQ41721730-DCBF95BD-429A-4B37-B18C-531F7B92CB7CQ41902469-73A16E30-6D9B-4366-904A-619E5F1B70B4Q42351254-767240C2-C5CC-4800-A48D-AF39427F8171Q42658896-DB46B0EC-8373-4E39-BE3B-C5AD7280B46AQ42775763-E8048F1C-907C-4C94-B87E-FF8B5CD9ACF4Q43207131-7915698D-0035-4308-A12B-3A6C23C4BD65Q47094065-E9FC9F5D-BD35-4F9A-BBB5-E0CB534F911DQ47097175-EFAFDC6D-8232-436E-9A21-936319BFC541Q47279488-F4F68420-37AD-4710-8CE0-90DB0335BFDCQ47580853-F02AD073-98F4-43A5-8B10-54C0FF8F00DFQ47754887-415B0775-A1C7-4796-843D-F523E045EF2BQ48137880-38296D6C-2B86-43C0-A8FE-A33830E9466FQ49517494-D1E3BF98-643D-4614-934D-EBA0B7B1E1B1Q50217919-41684151-47F1-4EE4-A9C7-D93F01CB0C5CQ51116884-6177EC6D-DC12-4BFD-A15A-9BD7E248B505Q51204276-284C0D68-FBD7-4A43-81CB-88F588F4536BQ56603206-4805D67D-F35D-4F27-9DD8-AB714C430577
P2860
description
2015 nî lūn-bûn
@nan
2015 թուականի Փետրուարին հրատարակուած գիտական յօդուած
@hyw
2015 թվականի փետրվարին հրատարակված գիտական հոդված
@hy
2015年の論文
@ja
2015年論文
@yue
2015年論文
@zh-hant
2015年論文
@zh-hk
2015年論文
@zh-mo
2015年論文
@zh-tw
2015年论文
@wuu
name
Chromatin signatures of cancer
@ast
Chromatin signatures of cancer
@en
Chromatin signatures of cancer
@nl
type
label
Chromatin signatures of cancer
@ast
Chromatin signatures of cancer
@en
Chromatin signatures of cancer
@nl
prefLabel
Chromatin signatures of cancer
@ast
Chromatin signatures of cancer
@en
Chromatin signatures of cancer
@nl
P2860
P3181
P356
P1433
P1476
Chromatin signatures of cancer
@en
P2093
Marc A. Morgan
P2860
P304
P3181
P356
10.1101/GAD.255182.114
P407
P577
2015-02-01T00:00:00Z